Additionally, bortezomib increased the phosphorylation of mitogen-activated protein kinase p38, Akt, and STAT5 in tumor infiltrating CD8+ T cells, uncovering a connection between PI3K/Akt/NF-κB/STAT5 pathways (12). The gene discussed is AKT1; the disease is neoplasm.